Verduyn-van Weegen Felice Isabel
SEC CIK 2094941 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | Dir, 10% | 5.29M | $25.00M | — | 3 | 2025-11-07 | 2026-02-17 |
Most active insiders at EVMN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Verduyn-van Weegen Felice Isabel | Dir, 10% | $25.00M | — |
| 2 | LSP 7 Cooperative UA | Dir, 10% | $25.00M | — |
| 3 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $20.00M | — |
| 4 | Pena Luis C. | Pres, CEO, Dir | — | $550.7K |
| 5 | Drew Janice Suzann | EVP, Ops | — | $452.6K |
| 6 | Carver Kyle | CFO | $13.3K | $415.1K |
| 7 | Patel Jeegar Pravinkumar | CSO | — | $412.9K |
| 8 | Moss Gregory S. | Chief Business, Legal Off | — | $324.7K |
| 9 | KIRSCH ARTHUR S | Dir | $133.0K | — |
| 10 | Cohen David E | Dir | — | $123.1K |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-02-18 | 2026-02-17 | EVMN | Evommune, Inc. | Verduyn-van Weegen Felice Isabel | Dir, 10% | A - Grant | $27.88 | +358.7K | 5.29M | +7% | +$10.00M |
| DI | 2025-11-12 | 2025-11-07 | EVMN | Evommune, Inc. | Verduyn-van Weegen Felice Isabel | Dir, 10% | C - Cnv Deriv | — | +3.37M | 3.37M | New | — |
| DI | 2025-11-12 | 2025-11-07 | EVMN | Evommune, Inc. | Verduyn-van Weegen Felice Isabel | Dir, 10% | P - Purchase | $16.00 | +1.56M | 4.93M | +46% | +$25.00M |
Purchase Sale Sale after option exercise All abbreviations